MedTrace Logo

International Guillain-Barré Syndrome Outcome Study

NCT01582763 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2024-12-12

No results posted yet for this study

Summary

International GBS Outcome Study (IGOS) is a study conducted by the members of the Inflammatory Neuropathy Consortium (INC) and Peripheral Nerve Society (PNS) on disease course and outcome in Guillain-Barré syndrome (GBS).

The IGOS aims to identify clinical and biological determinants and predictors of disease course and outcome in individual patients with Guillain-Barré syndrome, as early as possible after onset of disease.

Conditions

  • Guillain-Barré Syndrome
  • Miller Fisher Syndrome

Sponsors & Collaborators

Principal Investigators

  • Bart Jacobs, Dr. · Erasmus Medical Center

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-05-01
Primary Completion
2024-09-01
Completion
2024-12-02

Countries

  • United States
  • Argentina
  • Australia
  • Bangladesh
  • Belgium
  • Canada
  • China
  • Denmark
  • France
  • Germany
  • Greece
  • Italy
  • Japan
  • Malaysia
  • Netherlands
  • Puerto Rico
  • South Africa
  • Spain
  • Switzerland
  • Taiwan
  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01582763 on ClinicalTrials.gov